Skip to main content
# Title Research Member Research Year
81 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Assmaa Ahmed Mohamed 2019
82 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Dr. Iman Hassan Ahmed Hamada 2019
83 Sensitvity of flowcytometry immunphenotyping compared to Bone marrow morphology in diagnosis of multiple myeloma Prof. Douaa Mohamed Sayed Hussein 2019
84 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Prof. Eman Massad Zaki El-Hefny 2019
85 Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
Dr. Asmaa Mohamed Zahran Omar 2019
86 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Dr. Doaa Fathi Hagag Ahmed 2019
87 The Prognostic Implication of CD49d Expression by
Flow Cytometry and Trisomy 12 Detection by
Fluorescent in situ Hybridization in Chronic
Lymphocytic Leukemia
Dr. Noha gaber sayed 2019
88 PO-094: HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018
89 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Dr. Samar Muhammad mansour 2018
90 circulating mi RNA-21 and miRNA-23 expression signature as potential biomarkers for early detection of non-small cell lung cancer Dr. Asmaa Mohamed Zahran Omar 2018